Pepto-Bismol™ To Go

Drug Labeling and Warnings

Drug Details [pdf]

PEPTO-BISMOL TO GO- bismuth subsalicylate tablet 
The Procter & Gamble Manufacturing Company

Disclaimer: Most OTC drugs are not reviewed and approved by FDA, however they may be marketed if they comply with applicable regulations and policies. FDA has not evaluated whether this product complies.

----------

Pepto-Bismol™ To Go

Drug Facts

Active ingredient (in each tablet)

Bismuth subsalicylate 262 mg

Purposes

Upset stomach reliever and antidiarrheal

Uses

relieves

• travelers' diarrhea
• diarrhea
• upset stomach due to overindulgence in food and drink, including:
  • heartburn
  • indigestion
  • nausea
  • gas
  • belching
  • fullness

Warnings

Reye's syndrome

Children and teenagers who have or are recovering from chicken pox or flu-like symptoms should not use this product. When using this product, if changes in behavior with nausea and vomiting occur, consult a doctor because these symptoms could be an early sign of Reye's syndrome, a rare but serious illness.

Allergy alert: Contains salicylate.

Do not take if you are

• allergic to salicylates (including aspirin)
• taking other salicylate products

Do not use if you have

• an ulcer
• a bleeding problem
• bloody or black stool

Ask a doctor before use if you have

• fever
• mucus in the stool

Ask a doctor or pharmacist before use if you are taking any drug for

• anticoagulation (thinning the blood)
• diabetes
• gout
• arthritis

When using this product a temporary, but harmless, darkening of the stool and/or tongue may occur

Stop use and ask a doctor if

• symptoms get worse or last more than 2 days
• ringing in the ears or loss of hearing occurs
• diarrhea lasts more than 2 days

If pregnant or breast feeding, ask a health professional before use.

Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away.

Directions

• chew or dissolve in mouth
• adults and children 12 years and over: 2 tablets every 1/2 to 1 hour as needed
• do not exceed 8 doses (16 tablets) in 24 hours
• use until diarrhea stops but not more than 2 days
• children under 12 years: ask a doctor
• drink plenty of clear fluids to help prevent dehydration caused by diarrhea

Other information

• each tablet contains: calcium 140 mg
• sodium less than 1 mg
• salicylate 99 mg
• very low sodium
• sugar free
• avoid excessive heat (over 104°F or 40°C)

Inactive ingredients

adipic acid, calcium carbonate, flavor, magnesium stearate, mannitol, povidone, red 27 aluminum lake, red 40 aluminum lake, saccharin sodium, talc

Questions?

1-800-717-3786

Dist. by Procter & Gamble, Cincinnati OH 45202

PRINCIPAL DISPLAY PANEL - 12 Tablet Carton

NDC: 37000-016-12

Pepto-
BISMOL ™
To-Go

BISMUTH
SUBSALICYLATE
UPSET STOMACH
RELIEVER /
ANTIDIARRHEAL

5 SYMPTOM RELIEF
Nausea Heartburn Indigestion
Upset Stomach Diarrhea

12 CHEWABLE TABLETS

CHERRY

PEPTO-BISMOL TO GO 
bismuth subsalicylate tablet

Product Information
Product Type	HUMAN OTC DRUG	Item Code (Source)	NDC: 37000-016
Route of Administration	ORAL

Active Ingredient/Active Moiety
Ingredient Name	Basis of Strength	Strength
BISMUTH SUBSALICYLATE (UNII: 62TEY51RR1) (SALICYLIC ACID - UNII:O414PZ4LPZ)	BISMUTH SUBSALICYLATE	262 mg

Inactive Ingredients
Ingredient Name	Strength
ADIPIC ACID (UNII: 76A0JE0FKJ)
CALCIUM CARBONATE (UNII: H0G9379FGK)
MAGNESIUM STEARATE (UNII: 70097M6I30)
MANNITOL (UNII: 3OWL53L36A)
POVIDONE (UNII: FZ989GH94E)
D&C RED NO. 27 (UNII: 2LRS185U6K)
FD&C RED NO. 40 (UNII: WZB9127XOA)
ALUMINUM OXIDE (UNII: LMI26O6933)
SACCHARIN SODIUM (UNII: SB8ZUX40TY)
TALC (UNII: 7SEV7J4R1U)

Product Characteristics
Color	pink	Score	no score
Shape	ROUND	Size	16mm
Flavor	CHERRY	Imprint Code	Pepto;Bismol
Contains

Packaging
#	Item Code	Package Description	Marketing Start Date	Marketing End Date
1	NDC: 37000-016-12	12 in 1 BOTTLE, PLASTIC; Type 0: Not a Combination Product	03/01/2012
2	NDC: 37000-016-24	24 in 1 BOTTLE, PLASTIC; Type 0: Not a Combination Product	03/01/2012

Marketing Information
Marketing Category	Application Number or Monograph Citation	Marketing Start Date	Marketing End Date
OTC monograph final	part335	03/01/2012	06/01/2019

Labeler - The Procter & Gamble Manufacturing Company (004238200)

Revised: 6/2019

Document Id: 8bd82674-71cf-58af-e053-2995a90a0673

34390-5

Set id: ec5a8746-ecb0-47a2-adef-8e88ddfccc90

Version: 3

Effective Time: 20190621

 

The Pr